🔎 Trials Near Me

Home › Prostate Cancer › Oregon › Bend

Prostate Cancer clinical trials in Bend, OR

5 studies for Prostate Cancer are looking for participants at sites in and around Bend (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Saint Charles Health System, Bend
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Saint Charles Health System, Bend
  • Saint Charles Health System-Redmond, Redmond · 16 mi away
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

RecruitingPhase 3
  • Saint Charles Health System, Bend
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RecruitingPhase 3
  • Saint Charles Health System, Bend
  • Saint Charles Health System-Redmond, Redmond · 16 mi away
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

RecruitingPhase 2
  • Saint Charles Health System, Bend
  • Saint Charles Health System-Redmond, Redmond · 16 mi away
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Bend

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.